Avanos receives all regulatory approvals for AIP acquisition; closing expected by July 27

AVANOS MEDICAL, INC.

All required regulatory approvals received for acquisition by American Industrial Partners affiliates.
Transaction expected to close no later than July 27, 2026, subject to stockholder approval and other conditions.
Special stockholder meeting to approve the merger scheduled for July 22, 2026.
Avanos CEO David Pacitti and AIP Partner Joel Rotroff commented positively on the milestone.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.